$GEVO

Bloom Paul D sold $48K of GEVO

Bloom Paul D (CEO) sold 31,096 shares of Gevo, Inc. (GEVO) at $1.55 on 2026-08-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bloom Paul D
Published Aug 7, 2026, 9:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$GEVO
Neutral
medium confidence
Mentioned
$GEVO
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GEVONeutralLow
01

Why it matters

The newest disclosed fact is the specific open-market sale quantity, price, and post-transaction holdings, with confirmation that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

A disclosed insider sale can influence sentiment, but 10b5-1 labeling typically limits the actionable signal.

03

What to watch

Traders may want to compare this sale’s size and frequency to prior Form 4 activity to judge whether it is truly out of pattern.

Relevance 2/10Novelty 3/10Timing: filed after-hours on 2026-08-07, covering a sale dated 2026-08-06

Background

This is an SEC Form 4 insider transaction disclosure for Gevo, Inc., reported by CEO Paul D Bloom.

Company-level read

Ticker impact

$GEVONeutralMedium confidence
Context

Gevo CEO Paul D Bloom filed a Form 4 open-market sale of 31,096 shares at $1.5458 on 2026-08-06 under a 10b5-1 plan.

Expected impact

Limited near-term impact; any reaction is likely muted unless traders view the sale as unusual versus prior patterns.

Evidence & confidence

Form 4 provides a concrete transaction size and price, but the presence of a pre-arranged 10b5-1 plan generally lowers interpretive value for directional forecasting.

Market effects

No clear sector read-through from a single 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect routine liquidity needs rather than bearish expectations.

Key entities

  • Gevo, Inc.

    Company whose CEO insider transaction is disclosed on Form 4.

  • Paul D. Bloom

    Gevo CEO and reporting person who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GEVOMedAI 8/10

Gevo (GEVO) Q2 2026 Earnings Call Transcript

Gevo (GEVO) reported Q2 2026 revenue of $47 million, up 7% year over year, and non-GAAP adjusted EBITDA of $11 million. Full-year 2026 adjusted EBITDA guidance is now above $60 million. The company targets $70 million of 45Z tax credit monetization in 2026 and recorded a $176 million noncash impairment tied to exiting its ATJ-60 project.

$GEVOHigh

Gevo, Inc. (GEVO): Results of Operations and Financial Condition

Gevo, Inc. (GEVO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Gevo Reports Second Quarter Results and Raises Financial Expectations for Full-Year 2026 ENGLEWOOD, Colo. – August 6, 2026 – Gevo, Inc. (NASDAQ: GEVO), a leader in renewable fuels, chemicals and carbon management, today announced its financial results for the second

$GEVOMedAI 8/10

Why Is Gevo (GEVO) Stock Rocketing Higher Today

Gevo (NASDAQ: GEVO) shares rose about 7.5% after the company said it expects 2026 non-GAAP Adjusted EBITDA to be more than double prior estimates. Gevo attributed the upgrade to new carbon pathways, higher production, and cost reductions, and it announced Todd Werpy, Ph.D., joining its board. The stock is volatile and trades at $1.68.